“Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo”, J of Skin, vol. 10, no. 2, p. s753, Mar. 2026, doi: 10.25251/r559dc08.